I型干扰素失调驱动早发型与晚发型狼疮肾炎的不同致病通路
研究对21例经活检确诊的狼疮肾炎患者按发病时间分为早发型(n=10)和晚发型(n=11),比较肾组织RNA测序的I型干扰素基因签名表达。早发型患者抗dsDNA滴度(63.4 U/ml,P=0.024)和尿N-乙酰-β-D-氨基葡萄糖苷酶水平(39.4 U/l,P=0.005)显著高于晚发型(分别为7.3 U/ml和11.4 U/l),GSEA显示早发型I型干扰素通路富集并伴中性粒细胞趋化。作者认为早发型狼疮肾炎以I型干扰素活性升高和中性粒细胞驱动炎症为特征,反映更具侵袭性的表型。
要点
- 早发型狼疮肾炎患者抗dsDNA滴度(63.4 U/ml)显著高于晚发型(7.3 U/ml),P=0.024。
- 早发型患者尿N-乙酰-β-D-氨基葡萄糖苷酶水平(39.4 U/l)显著高于晚发型(11.4 U/l),P=0.005。
- GSEA显示早发型狼疮肾炎中I型干扰素通路富集,并伴中性粒细胞趋化。
核心结论
- 早发型狼疮肾炎以I型干扰素活性升高和中性粒细胞驱动炎症为特征,反映更具侵袭性的表型。
- 这些发现突出潜在治疗靶点并强调个体化治疗的重要性。
- 早期调节I型干扰素可能预防纤维化并改善早发型狼疮肾炎的肾脏结局。
研究设计与样本
- 研究纳入21例经活检确诊的狼疮肾炎患者,根据狼疮肾炎发病时间分为早发型(n=10)和晚发型(n=11)两组。
- 获取临床数据、实验室结果和组织学特征,对肾活检样本行RNA测序以检查基因表达。
- 使用edgeR识别差异表达基因,并用基因集富集分析(GSEA)分析I型干扰素基因签名。
主要发现
- 早发型狼疮肾炎患者抗dsDNA滴度为63.4 U/ml,显著高于晚发型患者的7.3 U/ml(P=0.024)。
- 早发型患者尿N-乙酰-β-D-氨基葡萄糖苷酶水平为39.4 U/l,显著高于晚发型患者的11.4 U/l(P=0.005)。
- 层次聚类识别出100个可区分两组的基因(50个上调、50个下调)。
- GSEA显示早发型狼疮肾炎中I型干扰素通路富集,并伴显著中性粒细胞趋化。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: Lupus nephritis (LN) is a leading cause of morbidity and mortality in systemic lupus erythematosus (SLE), affecting nearly half of the patients with SLE. Type I interferon (IFN) plays a central role in SLE and LN pathogenesis. This study explored the differential expression of type I IFN gene signatures (IFNGS) in renal tissues from early- and late-onset LN patients to uncover pathways linked to disease progression. METHODS: Twenty-one patients with biopsy-confirmed LN were analysed. Based on the timing of LN onset, patients were classified into early-onset (n = 10) or late-onset (n = 11) groups. Clinical data, laboratory results and histological features were also obtained. RNA sequencing was performed on the renal biopsy samples to examine gene expression. Differentially expressed genes were identified using edgeR, and gene set enrichment analysis (GSEA) was used for IFNGS. RESULTS: Patients with early-onset LN exhibited significantly higher anti-dsDNA titres (63.4 U/ml, P = 0.024) and urinary N-acetyl-β-D-glucosaminidase levels (39.4 U/l, P = 0.005) than those with late-onset LN (7.3 U/ml and 11.4 U/l, respectively). Hierarchical clustering identified 100 genes (50 upregulated and 50 downregulated) that differentiated the groups. GSEA revealed enrichment of type I IFN pathways in early-onset LN with prominent neutrophil chemotaxis. CONCLUSION: Early-onset LN is characterized by elevated type I IFN activity and neutrophil-driven inflammation, reflecting a more aggressive phenotype. These findings highlight the potential therapeutic targets and emphasize the importance of personalized treatment. Early modulation of type I IFN may prevent fibrosis and improve renal outcomes in early-onset LN.
引用
- Ichinose K, Hagiwara H, Kitamura M, et al. Type I interferon dysregulation drives distinct pathogenic pathways in early- and late-onset lupus nephritis. Rheumatology (Oxford). 2025. PMID: 40272885. doi:10.1093/rheumatology/keaf211
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。